Open access · CC-BY
via OpenAlex
Nicotinamide Riboside—The Current State of Research and Therapeutic Uses
Mario Mehmel, Nina Dimitrijević Jovanović, Urs P. Spitz
Nutrients · 2020 · ▲ 222 citations
Abstract
Nicotinamide riboside (NR) has recently become one of the most studied nicotinamide adenine dinucleotide (NAD+) precursors, due to its numerous potential health benefits mediated via elevated NAD+ content in the body. NAD+ is an essential coenzyme that plays important roles in various metabolic pathways and increasing its overall content has been confirmed as a valuable strategy for treating a wide variety of pathophysiological conditions. Accumulating evidence on NRs’ health benefits has validated its efficiency across numerous animal and human studies for the treatment of a number of cardiovascular, neurodegenerative, and metabolic disorders. As the prevalence and morbidity of these conditions increases in modern society, the great necessity has arisen for a rapid translation of NR to therapeutic use and further establishment of its availability as a nutritional supplement. Here, we summarize currently available data on NR effects on metabolism, and several neurodegenerative and cardiovascular disorders, through to its application as a treatment for specific pathophysiological conditions. In addition, we have reviewed newly published research on the application of NR as a potential therapy against infections with several pathogens, including SARS-CoV-2. Additionally, to support rapid NR translation to therapeutics, the challenges related to its bioavailability and safety are addressed, together with the advantages of NR to other NAD+ precursors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/nu12061616
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Mehmel, M., Jovanović, N.D., & Spitz, U.P. (2020). Nicotinamide Riboside—The Current State of Research and Therapeutic Uses. <em>Nutrients</em>. https://doi.org/10.3390/nu12061616
Vancouver
Mehmel M, Jovanović ND, Spitz UP. Nicotinamide Riboside—The Current State of Research and Therapeutic Uses. Nutrients. 2020. doi:10.3390/nu12061616.
BibTeX
@article{mario2020Nicoti,
title = {Nicotinamide Riboside—The Current State of Research and Therapeutic Uses},
author = {Mario Mehmel and Nina Dimitrijević Jovanović and Urs P. Spitz},
journal = {Nutrients},
year = {2020},
doi = {10.3390/nu12061616},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2019
Open access · CC-BY
Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis
International Journal of Molecular Sciences 2025
Open access · CC-BY
Mechanistic Insights into Anti-Melanogenic Effects of Fisetin: PKCα-Induced β-Catenin Degradation, ERK/MITF Inhibition, and Direct Tyrosinase Suppression
ACS Biomarker 2016
Open access · US-GOV
Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure. A Proof of Concept Clinical Trial Within the EU FP 7 (European Union FP7) "HOMAGE" Programme " Heart OMics in AGing "
Antioxidants 2021
Open access · CC-BY
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
PubMed 2016
Preprint
The pathophysiological importance and therapeutic potential of NAD' biosynthesis and mitochondrial sirtuin SIRT3 in age-associated diseases.
International Journal of Molecular Sciences 2025
Open access · CC-BY